Inspire Pharmaceuticals' stock price fell by 13.4% after the company announced a setback in its drug development.
Drug developer Inspire Pharmaceuticals Inc . ( nasdaq : ISPH - news - people ) tumbled $ 2.17 , or 13.4 percent , to $ 13.98 .